Purchases and Sales Made in Q4 2022 in Acurx Pharmaceuticals, Inc. (ACXP)
This table provides information about the institutional ownership of Acurx Pharmaceuticals, Inc. (ACXP) during Q4 2022. The information is specifically focused on institutions that hold shares of Acurx Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 08, 2023
Q4 2022
|
Belpointe Asset Management LLC
|
BUY
|
- |
3KNew |
$8.25K - $12.3K
|
3K
$2.19K
|
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
1.04K+ 1.37% |
$2.87K - $4.27K
|
77.3K
$56.4K
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
90+ 0.58% |
$248 - $369
|
15.6K
$11.4K
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
10New |
$27.5 - $41
|
10
$7.3
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 5.17% |
$8.25 - $12.3
|
61
$44.5
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-7- 0.24% |
$19.3 - $28.7
|
2.9K
$2.11K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-1.35K- 33.09% |
$3.72K - $5.55K
|
2.74K
$2K
|
|
|
Nov 13, 2023
Q4 2022
|
Td Waterhouse Canada Inc.
Toronto, A6 |
SELL
|
- |
-11.3K- 37.81% |
$31.2K - $46.5K
|
18.7K
$13.6K
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-18.3K- 38.6% |
$50.3K - $75K
|
29.1K
$21.2K
|
|
|
Feb 14, 2023
Q4 2022
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-186K- 17.45% |
$512K - $763K
|
880K
$642K
|